Tenaya receives Nasdaq bid price deficiency notice; must regain compliance by Oct 13, 2025

Tenaya Therapeutics, Inc.

Closing bid price of TNYA common stock below $1.00 for 30 consecutive business days through April 12, 2025.
Nasdaq granted 180-day compliance period ending October 13, 2025; no immediate impact on listing.
To regain compliance, shares must close at $1.00 or higher for at least 10 consecutive business days.
If not cured, Company may seek a second 180-day period by transferring to Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.